Jan Van Elslande
Overview
Explore the profile of Jan Van Elslande including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
513
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Van Elslande J, Kerckhofs F, Cuypers L, Wollants E, Potter B, Vankeerberghen A, et al.
Viruses
. 2022 Jun;
14(6).
PMID: 35746671
We report two clusters of SARS-CoV-2 B.1.617.2 (Delta variant) infections in a group of 41 Indian nursing students who travelled from New Delhi, India, to Belgium via Paris, France. All...
12.
Steels S, Van Elslande J, De Munter P, Bossuyt X
J Clin Immunol
. 2022 Mar;
42(4):742-745.
PMID: 35296990
No abstract available.
13.
Van Elslande J, Oyaert M, Lorent N, Vande Weygaerde Y, Van Pottelbergh G, Godderis L, et al.
Diagn Microbiol Infect Dis
. 2022 Mar;
103(1):115659.
PMID: 35278794
We retrospectively compared the long-term evolution of IgG anti-spike (S) and anti-nucleocapsid (N) levels (Abbott immunoassays) in 116 non-severe and 115 severe SARS-CoV-2 infected patients from 2 university hospitals up...
14.
Van Elslande J, Weemaes M, Godderis L, Van Pottelbergh G, Bossuyt X, Vermeersch P
Diagn Microbiol Infect Dis
. 2022 Feb;
102(4):115638.
PMID: 35104720
We report IgG anti-spike levels up to 3 months after vaccination with 2 doses of BNT162b2 mRNA vaccine in healthcare workers (HCW). The antibody response was significantly stronger in previously...
15.
Verbeek J, Vrij C, Vermeersch P, Van Elslande J, Vets S, Lagrou K, et al.
Transplantation
. 2021 Sep;
106(4):862-868.
PMID: 34534192
Background: There is a paucity of data on the prevalence, adequate timing, and outcome of solid organ transplantation after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and the kinetics of...
16.
Delayed diagnosis and treatment of extreme hypertriglyceridemia due to rejection of a lipemic sample
Van Elslande J, Hijjit S, De Vusser K, Langlois M, Meijers B, Mertens A, et al.
Biochem Med (Zagreb)
. 2021 Apr;
31(2):021002.
PMID: 33927560
Introduction: Most laboratories routinely determine haemolysis, icterus and lipemia indices to identify lipemic samples and reject potentially affected results. Hypertriglyceridemia is the most common cause of lipemia and severe hypertriglyceridemia...
17.
Van Elslande J, Gruwier L, Godderis L, Vermeersch P
Clin Infect Dis
. 2021 Mar;
73(12):2366-2368.
PMID: 33693643
No abstract available.
18.
Van Elslande J, Oyaert M, Ailliet S, Van Ranst M, Lorent N, Vande Weygaerde Y, et al.
J Clin Virol
. 2021 Feb;
136:104765.
PMID: 33636554
Background: Most SARS-CoV-2 infected patients develop IgG antibodies within 2-3 weeks after symptom onset. Antibody levels have been shown to gradually decrease in the first months after infection, but few...
19.
Van Elslande J, Andre E, Van Ranst M, Lagrou K, Vermeersch P
Lancet Infect Dis
. 2020 Nov;
21(5):e120.
PMID: 33137289
No abstract available.
20.
Buntinx F, Claes P, Gulikers M, Verbakel J, Jan D, Van der Elst M, et al.
Acta Clin Belg
. 2020 Oct;
77(2):295-300.
PMID: 33070766
Objectives: To examine the added value of anti-SARS-CoV-2 antibody testing in a nursing home during an acute COVID-19 outbreak. RT-PCR is the gold standard, but can be false-negative. Methods: 119...